Back to Authors

Li, Qing

0000-0002-8632-9637

Mayo Clinic

Constellation Pharmaceuticals (United States)

Citations 1

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
Patriarca, Andrea, Rivera, Candido E., Granacher, Nikki, Palmer, Jeanne , Rampal, Raajit K. , Eliane, Jean-Pierre, Chang, Tzuu-Wang, Klein, Sandra, Colak, Gozde , Harrison, Claire , Passamonti, Francesco , Patriarca, Andrea , Knapper, Steven , Scandura, Joseph Michael , Devos, Timothy , Mead, Adam J. , Oh, Stephen T. , Teichmann, Lino Lars , Li, Qing

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e9927843

10.1097/01.hs9.0000967584.99278.43 Get It